Piero Ruggiero

Piero Ruggiero has extensive work experience in the pharmaceutical industry. Piero is currently working at SpringWorks Therapeutics, where they hold the position of Director of CMC Synthetic Chemistry since July 2022. Prior to this role, they served as an Associate Director of CMC Synthetic Chemistry at the same company from September 2019 to August 2022.

Before joining SpringWorks Therapeutics, Piero worked at Altavant Sciences as an Associate Director of Pharmaceutical Development from May 2018 to August 2019.

Piero began their career at Vertex Pharmaceuticals in 2005, where they held various scientific positions. Piero was a Senior Scientist from August 2014 to April 2018, Scientist II from October 2010 to August 2014, and Scientist I from August 2005 to February 2011.

Overall, Piero Ruggiero has a strong background in synthetic chemistry and pharmaceutical development, with experience across different levels of responsibility.

Piero Ruggiero completed their Bachelor of Science degree in Medicinal Chemistry at the University at Buffalo from 1990 to 1995. Piero then pursued their PhD in Synthetic Organic Chemistry at the University of Rochester from 1995 to 2002. After completing their doctorate, they continued their studies at the University of Rochester as a Postdoctoral researcher in Organic Chemistry from 2002 to 2005.